NewPassiveContact Us

OXIPASSIVE®

OOCYTE QUALITY SUPPORT

During Assisted Reproductive Technology (ART)

Restoring Glutathione.Restoring Oocyte Competence.

Where Successful Embryo Development Begins.

  • Oocyte Competence

  • Mitochondrial Function

  • Embryo Development

  • Oxidative Stress

  • NF-κB Activation

How Oxipassive® Restores Oocyte Competence

Oxipassive® Dual-Precursor Strategy

  1. N-Acetylcysteine

  2. Glycine

  3. Glutathione (GSH)

  4. Healthy Mitochondria

  5. Healthy Follicular Micro-environment

Pathology & Clinical Management

Understanding the multi-faceted cellular profile of Metabolic PCOS.

Patient Profile

Line illustration of a woman
Diagnosis:
PCOS
Planned ART:
IVF or ICSI
Clinical Findings:
Poor Oocyte Competence · Oxidative Stress · Suboptimal Follicular Microenvironment

Women with PCOS undergoing IVF or ICSI often present with impaired oocyte competence and increased oxidative stress.

Oxipassive®

Targeted Co-Treatment for Oocyte Quality Support

  • 1 capsule twice daily
  • Begin 6–12 weeks before IVF / ICSI
  • Adjunctive antioxidant support before Assisted Reproductive Technology
Clipboard with a capsule

WHY OXIDATIVE STRESS MATTERS

  1. Mitochondrial Dysfunction

  2. Reduced GDF-9 Expression

  3. Increased E-selectin Expression

WHY NAC SUPPORTS OOCYTE COMPETENCE DURING ART

  • Protects oocytes from oxidative injury
  • Supports mitochondrial integrity
  • Improves GDF-9 expression
  • Supports healthy oocyte maturation

The Science Behind Oocyte Protection

How Glycine Supports Mitochondrial Bioenergetics During ART

  • supports mitochondrial ATP production
  • maintains intracellular redox balance
  • protects reproductive cells
  • supports embryo developmental competence

Why Glynac Before IVF/ICSI

  • restores endogenous glutathione
  • optimizes the follicular microenvironment
  • supports oocyte competence
  • complements IVF/ICSI protocols

Art Support Algorithm

Co-Treatment Integration Pathway

  1. Pre-IVF/ICSI Preparation

    Initial clinical evaluation and baseline redox profiling

  2. Oxipassive®

    Targeted co-treatment protocol (6–12 weeks prior)

  3. Healthy Follicular Microenvironment

    Restoring endogenous glutathione pool and mitigating ROS

  4. Healthy Oocyte Competence

    Restoring intracellular mitochondrial bioenergetics

  5. Improved Embryo Development Potential

    Optimizing oocyte quality parameters

  6. IVF / ICSI

    Assisted Reproductive Technology procedure

Treatment Algorithm

Step-by-Step Protective Cascade

  1. Healthy Mitochondria

    Restores crucial cellular energy systems

  2. Healthy Oocyte

    Protects follicle structure from localized ROS

  3. Improved Oocyte Competence

    Supports natural cellular maturation pathways

  4. Healthy Embryo Development

    Lays robust biological foundations

  5. Improved ART Potential

    Optimizes cumulative pregnancy potential

Clinical Positioning

Ideal as adjunctive antioxidant support alongside IVF or ICSI in women with PCOS undergoing ART.

  • Poor oocyte competence

  • Oxidative stress-associated ovarian dysfunction

  • Mitochondrial dysfunction

  • Reduced embryo developmental potential

Clinical Evidence

Peer-reviewed scientific validation supporting glutathione dual-precursor therapy.

Clinical Review, Oocyte Mitochondrial Function

Mitochondrial Function

PMCID: PMC7761442